Skip to main content

Peer Review reports

From: Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis

Original Submission
30 Aug 2022 Submitted Original manuscript
11 Sep 2022 Reviewed Reviewer Report - Alessandro Pupino
6 Oct 2022 Reviewed Reviewer Report
6 Dec 2022 Author responded Author comments - Jiann-Torng Chen
8 Dec 2022 Author responded Author comments - Jiann-Torng Chen
Resubmission - Version 2
6 Dec 2022 Submitted Manuscript version 2
13 Dec 2022 Author responded Author comments - Jiann-Torng Chen
Resubmission - Version 3
13 Dec 2022 Submitted Manuscript version 3
23 Dec 2022 Author responded Author comments - Jiann-Torng Chen
Resubmission - Version 4
23 Dec 2022 Submitted Manuscript version 4
Publishing
11 Jan 2023 Editorially accepted
27 Jan 2023 Article published 10.1186/s12886-023-02780-0

You can find further information about peer review here.

Back to article page